CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program

Keyphrases

• Clinical Outcomes 100%
• Percutaneous Coronary Intervention 100%
• Acute Coronary Syndrome 100%
• Million Veteran Program 100%
• CYP2C19 Polymorphism 100%
• Adjusted Hazard Ratio 83%
• Adverse Cardiac Events 83%
• Stable Ischemic Heart Disease 66%
• Clopidogrel 50%
• Loss Function 33%
• Gain-of-function mutation 33%
• Genotype 33%
• CYP2C19 33%
• Confidence Interval 16%
• Older Patients 16%
• Myocardial Infarction 16%
• Clinical Factors 16%
• Cardiovascular Mortality 16%
• Non-carriers 16%
• Disease Groups 16%
• Program Participant 16%
• Antiplatelet Activity 16%
• Real-world Population 16%
• Older Veterans 16%
• Functional Carriers 16%
• Cardiac Event Risk 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Coronary Syndrome 100%
• CYP2C19 100%
• Major Adverse Cardiac Event 83%
• Ischemic Heart Disease 66%
• Clopidogrel 50%
• Heart Infarction 16%
• Antiplatelet 16%
• Cerebrovascular Accident 16%